Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARC041: Phase 3 Randomized Double-Blind Study of Abemaciclib Versus Placebo in Patients With Advanced Dedifferentiated Liposarcoma

NCT04967521 is registered in ClinicalTrials.gov with Sarcoma Alliance for Research through Collaboration as lead sponsor.

NCT NCT04967521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04967521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARC041: Phase 3 Randomized Double-Blind Study of Abemaciclib Versus Placebo in Patients With Advanced Dedifferentiated Liposarcoma
Lead sponsor
Sarcoma Alliance for Research through Collaboration
Phase
Phase 3
Overall status
Active, not recruiting
Start date
November 11, 2021
Completion date
December 31, 2027
Enrollment
108 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

advanced dedifferentiated liposarcoma